Joey G. Sheff
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target.
Journal: Science translational medicine
Published: May 13, 2026
Epitope Screening by Hydrogen-Deuterium Exchange Mass Spectrometry for Improved Immunotherapeutic Outcomes.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: October 14, 2025
Broadly reactive anti-VHH antibodies for characterizing, blocking, or activating nanobody-based CAR-T cells.
Journal: Antibody therapeutics
Published: November 21, 2024
A Novel Antigen Design Strategy to Isolate Single-Domain Antibodies that Target Human Nav1.7 and Reduce Pain in Animal Models.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 17, 2024
Influence of variant-specific mutations, temperature and pH on conformations of a large set of SARS-CoV-2 spike trimer vaccine antigen candidates.
Journal: Scientific reports
Published: April 12, 2023
Author Correction: Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease.
Journal: Scientific reports
Published: January 18, 2023
Epitope mapping of a blood-brain barrier crossing antibody targeting the cysteine-rich region of IGF1R using hydrogen-exchange mass spectrometry enabled by electrochemical reduction.
Journal: Journal of biochemistry
Published: August 03, 2022
Arsenal of nanobodies shows broad-spectrum neutralization against SARS-CoV-2 variants of concern in vitro and in vivo in hamster models.
Journal: Communications biology
Published: January 07, 2022
Hydrogen-deuterium exchange mass spectrometry reveals three unique binding responses of mAbs directed to the catalytic domain of hCAIX.
Journal: mAbs
Published: November 23, 2021
Structures and Dynamics of Native-State Transmembrane Protein Targets and Bound Lipids.
Journal: Membranes
Published: May 20, 2021
Defining the epitope of a blood-brain barrier crossing single domain antibody specific for the type 1 insulin-like growth factor receptor.
Journal: Scientific reports
Published: June 25, 2020
Last Updated: 09/26/2026